Amlodipine

Active ingredient description

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Amlodipine
C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA01

Medicines

Amlodipine is the active ingredient of these drugs:

Drug
Countries

Hong Kong Singapore

Cyprus Hong Kong

Lithuania

Brazil

Lithuania

Hong Kong

Singapore

Singapore

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Cyprus

Hong Kong

Singapore

Hong Kong

Ireland

Tunisia

Hong Kong Lithuania

Brazil

Austria

Austria

Tunisia

Tunisia

Hong Kong

Hong Kong Singapore

Hong Kong Singapore

Hong Kong

France Tunisia

Cyprus Hong Kong

Singapore

Ireland

Hong Kong Singapore Tunisia

Hong Kong

Brazil Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong Singapore

Hong Kong

Brazil

Hong Kong Singapore

Brazil

Spain

Singapore

Brazil

Cyprus

Tunisia

Hong Kong

Brazil

Lithuania

Hong Kong

Hong Kong

Hong Kong

Ireland United Kingdom

Hong Kong

United States

Tunisia

Tunisia

Singapore

Hong Kong

Hong Kong

Hong Kong

Tunisia

Tunisia

Brazil

Australia

Hong Kong Singapore

Australia

Spain

Australia Austria Brazil Canada Cyprus

Brazil

Brazil

Hong Kong

Singapore

Singapore

Brazil

Lithuania Singapore

Brazil

Hong Kong

Singapore

Spain

Hong Kong Singapore

Amlodipine is also found within below combination drugs:

ACERTANLO , ACERYCAL , ALBIS , ALBIS PLUS , ALOTENDIN , AMELIOR , AMELIOR PLUS , AMLESSA , AMLOVALSAX , AMLOVAR , AMODUO , APROFORT , APROVASC , ARADEUX PLUS , ARAVEN IC , ARPLEXAM , ASBIMA , ASTUCOR , ATORDAPIN , ATORVALAN COMP , AXELER , AZOR , AZOREN , BALZAK , BALZAK PLUS , BENICAR TRIPLO , BENICARANLO , BETALOR , BEVACOMB , BIPROCARD AMLO , BIRAMLO , BISOCOR AMLO , BISODIPIN , BRANTA , BRASART BCC , BRAVAN DUO , CADIVAST , CADUET , CAMLOSTAR , CANDAM , CANDECAM , CANDECOR-AMLO , CAPENON , CAPENON HCT , CARAMLO , CO-AMLESSA , CO-THERAPRIL , CODUWON , CONCOR AMLO , CONCOR ANLO , CONSENSI , COPALIA , COPALIA HCT , COREYRA , COSARTAN ALP , COVERAM , COVERDINE , COZAAR-XQ , DAFIRO , DAFIRO HCT , DALNESSA , DIOVAN AMLO FIX , DIPPERAM , DIPPVOL , DIRONORM , DUOFOR , DUOFOR PLUS , DUOTRESTAR , EXFORGE , EXFORGE HCT , FLUDEXAM , FLUTENSIF , FLUXOCOR ANLO , GADUAR , HIFORGE , HIPOVAS , ICATENS , IMPRIDA , KONVERGE , KONVERGE PLUS , LIPERTANCE , LIPTA , LISAM , LOSAMLO , LOTAR , LOTREL , MICARDIS ANLO , NAPRIX A , NATRIXAM , NORVAN , OLMEDIPIN , OLMEKAR , OLMEKAR HCT , OLMETECANLO , OLMIRA , OLMY ANLO , OLSITRI , ORIZAL , ORIZAL PLUS , PREMINOR , PRESS PLUS , PRESTALIA , PRESTERAM , PRESUCOMB , PRYLAR , RAMDACORDIA , RAMI-AMLO , RAMIDIPIN , RAMLON , RASILAMLO , RAVENTON , REAPTAN , REVERANTZA , ROSVADEN , ROXAMPEX , SANORAL , SANORAL HCT , SARTESTA , SEVIKAR , SEVIKAR HCT , SEVIKAR PLUS , SINERGEN , TENLORIS , TILAMCAR , TONARSSA , TONOTEC , TRIBENZOR , TRIPLIXAM , TRITAMLO , TRIVERAM , TWYNSTA , VALSAM , VALSIMIA , VALTRICOM , VIACORAM , VIACORLIX , VIDONORM , VOCADO , WAMLOX , ZENICAMO

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured product labeling (SPL/PLR)
US
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

1J444QC288 - AMLODIPINE

CAS registry number

88150-42-9 - amlodipine

SNOMED-CT

386864001 - Amlodipine (substance)